Sign in

CIK 0001665988 · Accelerated filer<br>Emerging growth company

Bioventus Inc.

Sign in to watch
Ticker
BVS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
810980861
Phone
(919) 474-6700
Business address
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
  1. 4 Open-market buy Director bought 292,126 shares at an average $3.38 ($987,185)
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 4 Open-market buy Director bought 455,725 shares at an average $2.94 ($1,338,164)
  4. 4 Option exercise Director acquired 16,648 shares (option exercise)
  5. 8-K Event Executive or director change · Shareholder vote results
  6. 4/A Open-market sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
  7. 4 Option exercise Director acquired 16,648 shares (option exercise)
  8. 4 Option exercise Director acquired 16,648 shares (option exercise)
  9. 4 Option exercise Director acquired 16,648 shares (option exercise)
  10. 4 Option exercise Director acquired 16,648 shares (option exercise)
  11. 4 Option exercise Director acquired 16,648 shares (option exercise)
  12. 4 Option exercise Director acquired 16,648 shares (option exercise)
  13. 4 Option exercise Director acquired 16,648 shares (option exercise)
  14. 4 Option exercise Director acquired 7,576 shares (option exercise)
  15. 4 Open-market buy Director bought 88,000 shares at an average $2.68 ($235,567)
  16. 8-K Event Acquisition or sale completed · Other events
  17. 4 Open-market buy Interim CEO bought 125,000 shares at $2.33 ($290,988)
  18. SC 13D/A Stake Beneficial Ownership Report
  19. 4 Open-market buy Director bought 1,315,673 shares at an average $1.96 ($2,573,128)
  20. 10-Q Report Quarterly Report

Page 12 of 24 · 463 filings